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Schiff base ligands such as methyl 4-[(2-butyl-4-chloro-5-formyl-1H-imidazol-1-yl)methyl]benzoate thiosemicarbazone 
(L1) and 2-butyl-4-chloro-5-formylimidazole 2,4-dinitrophenylhydrzone (L2) are designed and synthesized via the reaction 
between methyl 4-[(2-butyl-4-chloro-5-formyl-1H-imidazol-1-yl)methyl]benzoate & thiosemicarbazide for L1and 2-butyl-4-
chloro-5-formylimidazole & 2,4-dinitrophenylhydrazine for L2.Schiff bases are characterized by FT-IR, UV-visible, mass 
spectrometry,1H and 13C-NMR spectral studies. These ligands are individually tested for their antimicrobial activities for both 
gram positive and gram negative to examine their inhibition potential by well diffusion method. The corrosion inhibition 
property of all the three ligands L1, L2 & L3 on mild steel in 0.5 N HCl solution has been investigated at different concentrations 
and different temperatures by weight loss method. The biological activity of L2 has shown better activity against gram negative 
bacteria such as E-coli, Klebsiella pneumonia, Acinetobacter baumannii, Pseudomonas aeruginosa and gram positive bacteria 
Staphylococcus aureus when compared to standard ligand L3. All the three ligands exhibit good corrosion inhibition property on 
mild steel in 0.5N HCl solution even at 0.1% concentration level and the rate of corrosion of mild steel is increased with 
increase of temperature of corrosion medium. 
Keywords: Antibacterial activity, Butyl chloro formyl imidazole, Corrosion inhibition, Phenyl hydrazine, Schiff base 
ligand, Thiosemicarbazide. 
The heterocyclic compounds are backbone of several 
biologically active compounds
1,2
. The design and study 
of Schiff base containing sulfur donor atom is interesting 
field of inorganic and bioinorganic chemistry
3-5
. 
Thiosemicarbazone are exhibit cytotoxic activity against 
a series of murine and human tumor cells in culture
6,7
. 
The chemistry of imidazole was reviewed in literature 
























 etc., Hydrazone derivatives exhibit 
physiological activities in the treatment of tuberculosis. 
They also exhibit as herbicides, insecticides, 
nematocides, rodenticides, plant growth regulator
18
. The 
nitro group is a strong electron withdrawing group and 
nitro Schiff bases plays an important role in affecting the 
reactivity and enantioselectivities in synthesis as 
catalyst. Recently reported Schiff bases containing O, N 
or S atom possess an effective corrosion inhibition for 
mild steel
19
 and other metals
20
. The lone pair of electrons 
on heteroatoms in a compound has been reported to be 
an efficient corrosion inhibitor for metals and alloys. In 
an acidic environment, organic compounds with more 
than one heteroatom’s containing electrons exhibit high 
corrosion inhibiting properties by providing electrons to 
interact with metal surface
21
. The efficient of corrosion 
inhibition property increases by the presence of either  
π-electrons of aromatic system or presence of 
electronegative groups (Nitro). The π-electrons facilitate 
the interaction with d-orbital electron of iron
22
. 
Losartan and Eprosartan are the antihypertensive 
drugs which contain buylchloroimidazole (Losartan, 
Allisartan) and butyimidazolechalcone (Eprosartan) 
skeleton illustrated in Fig. 1. 
2-Butyl-4-chloro-5-formyl imidazole (BCFI) is an 
important intermediate used as precursors for 
designing a variety of antihypertensive drugs. It was 
reported that butylchloroimidazole derivatives are 
gained synthetic interest in recent years since it 
exhibits broad spectrum of biological properties
23
. 
Also butyl chloro imidazole chalcones and pyrazoles 
act as good inhibitors for angiotensin converting 
enzyme
24
.The nitro benzyl 2-butyl-4-chloroimidazole 
derivative act as anti-inflammatory and analgesic 
activity
25
. The nickel complex of Schiff base derived 




from BCFI and ethylenediamine showed excellent 
activity against E. coli bacteria
26
.  
By keeping all the above facts in mind, in the 
present work we made an effort to design and 
synthesis a new butyl chloro imidazole Schiff base 
ligands illustrated in Fig. 2. The synthesis of standard 
ligand L3 has been described
27
. The L1 has been 
designed by protecting the imidazole –NH group of 
 
 




Fig. 2 ― New Schiff base design strategy 




standard L3 with benzyl-4-methylbenzoate ester group 
and the L2 has been designed by replacing the amine 
part of standard L3 with 2,4-dinitrophenylhydrazine. 
The antimicrobial studies against gram positive and 
gram negative pathogens and corrosion inhibition 
property for mild steel in 0.5N HCl at different 




Materials and methods 
All chemicals and solvents used in the present 
work were of analytical grade. 2-butyl-4-chloro-5-
formyl imidazole and methyl 4-[(2-butyl-4-chloro-5-
formyl-1H-imidazol-1-yl)methyl]benzoate were 
purchased from sigma-Aldrich. Thiosemicarbazide, 
2,4-dinitrophenylhydrazine, were purchased from SD 
fine chemicals. Acetic acid, concentrated hydrochloric 
acid, methanol, ethanol was purchased form Merck. 
 
Instrumentation 
The electronic spectra of the compound were 
recorded using a PerkinElmer LS 45 UV-Visible 
spectrophotometer. The IR spectrums were recorded 
by using JASCO FT/IR-6300 attenuated total 
reflection Fourier transform infrared spectrometer 
(ATR-FTIR). The mass spectrums were recorded by 
using of mass spectrometer Jeol GC MATE-II EI 
mass equipped with energy of 70ev. The NMR 
spectrum is recorded on a Bruker (400MHz) 
spectrometer at 297.7 K, using DMSO-d6 and CDCl3 
as a solvent and tetramethylsilane (TMS) as an 
internal reference compound. 
 
Synthesis of Ligand-1(L1) 
Methyl 4-[(2-butyl-4-chloro-5-formyl-1H-imidazol-
1-yl)methyl]benzoate(1)(10mmol;1g) in ethanol(10 ml) 
was added to thiosemicarbazide(2)(10mmol;0.27g) in 
ethanol(10ml). 5-10 drops of acetic acid was added. 
The reaction mixture was refluxed for about 1h. The 
progress of the reaction was monitored by TLC (1:1 
ethylacetate+hexane system) and cooled to room 
temperature. The white precipitate formed was filtered 
and washed with ethanol. The solid was dried under 
vacuum at room temperature to yield the L1 (3) and 
recrystallized from hot ethanol. The reaction scheme is 
shown in Scheme-1. 
Yield : 85%, Description: white powder, 
HRMS(m/z): Calcd for [C18H22O2N5S1Cl1]
+
 is 407.9 
Found: 407.89, IR(cm
-1
): γ(N-H) 3398, γ(NH2) 3248, 
γ(C=N) 1605, γ(C=S) 795, γ(N-N) 1102, γ(C=O, 
ester) 1727, γ(C-Cl) 843, γ(aliphatic, aromatic C-H) 
2947, γ(aromatic C=C) 1532, 1462. 
1
H NMR(d6-
DMSO)(ppm) : ∂=0.81 (3H, t, butylCH3), ∂=1.22-
1.28(2H, m, butylCH2), ∂=1.46-1.52(2H, m, 
butylCH2), ∂2.6-2.63(2H, t, butylCH2), ∂=3.82(3H, s, 
esterCH3), ∂=5.7 (2H, s, N-CH2), ∂=8.02(1H, s,-NH2), 
∂8.09(1H, s, -NH2), ∂=6.9(1H, s, -CH), ∂=7.10-
7.12(2H, d, AroCH), ∂=7.89-7.91(2H, d, AroCH), 
∂=11.27(1H, s, -NH).
13
C NMR (d6-DMSO) (ppm): 
∂=14.0, 22.0, 26.0, 29.4, 48.4, 52.5, 120.8, 126.4, 
129.0, 130.0, 132.3, 133.3, 143.1, 152.1, 166.3, 177.6. 
 
Synthesis of Ligand-2(L2) 
2-Butyl-4-chloro-5-formylimidazole (4) (10m 
moL;1g) in methanol (10mL) was added to 2,4-
dinitrophenylhydrazine (5) (10m mol;1.06 g) in 
methanol (10 mL) followed by the addition of 5-10 
drops of concentrated hydrochloric acid. The reaction 
mixture was stirred at room temperature about 3-4 H. 
The progress of the reaction was monitored by TLC 
(20%Ethyl acetate in hexane system). The red 
precipitate obtained was filtered and washed with 
methanol and then dried the solid under vacuum at 
room temperature to yield the L2 (6). The solid was 
recrystallized from hot ethanol.The reaction scheme is 
shown in Scheme 2. 
Yield : 87%, Description: Red orange powder, 
HRMS(m/z): Calcd for[C14H15O4N6Cl1]
+
 is 366.7 
Found: 366.69, IR(cm
-1
): γ(N-H) 3276, γ(NO2) 1511, 
 
 
Scheme 1 ― Preparation of L1 




γ(C=N) 1612, γ(N-N) 1138, γ(C-Cl) 839, γ(aliphatic, 
aromatic C-H) 3106 & 2960, γ(aromatic C=C) 1423. 
1
H NMR(CDCl3) (ppm): ∂=0.95-0.98(3H, t, 
butylCH3), ∂=1.38-1.48(2H, m, butylCH2), ∂=1.74-
1.82(2H, m, butylCH2), ∂=2.76-2.79(2H, t, butylCH2), 
∂=7.2-8.3(2H, AroCH), ∂=9.15(1H, s, -CH), 
∂=9.46(1H, s, -NH), ∂=11.3(1H, s, Imidazole-NH). 
13
C NMR(DMSO) (ppm):14.0, 22.1, 28.1, 30.2, 
117.4, 123.5, 129.5, 129.8, 137.2, 137.6, 144.8, 151.7. 
 
Synthesis of Ligand-3(L3) 
2-Butyl-4-chloro-5-formylimidazole (7) (10mmol; 
1g) in ethanol (10 mL) was added to 
thiosemicarbazide (8) (10mmol;0.49g) in ethanol  
(10 mL) followed by 5-10 drops of acetic acid was 
added. The reaction mixture was refluxed for about 
1h. The progress of the reaction was monitored by 
TLC (1:1 Ethylacetate+hexane system). The reaction 
mixture was cooled to room temperature and the 
white precipitate formed was filtered and washed with 
ethanol. The solid was dried under vacuum at room 
temperature to yield the L3 (9). Then it was 
recrystallized from hot ethanol. The reaction scheme 
is shown in Scheme 3. 
Yield : 84%, Description: white powder, HRMS 
(m/z): Calcd for[C9H14N5S1Cl1]
+
 is 259.7 Found: 259.1, 
IR (cm
-1
): γ(N-H) 3353, γ(NH2) 3258, γ(C=N) 1606, 
γ(aliphatic, C-H) 3171 & 2925, γ(N-N) 1244, γ(C-Cl, 
C=S) 817, γ(aromatic C=C) 1477 & 1509.
1
H NMR 
(ppm) : ∂=0.88-0.91(3H, t, butylCH3), ∂=1.30-1.32 (2H, 
m, butylCH2), ∂=1.61-65(2H, m, butylCH2), ∂=2.59-
2.63(2H, t, butylCH2), ∂=7.83(1H, s, -NH2), ∂7.95(1H, s, 
-NH2), ∂=8.33(1H, s, -CH), ∂=11.45(1H, s, N-NH).
13
C 
NMR(d6-DMSO) (ppm): ∂=14.0, 22.1, 28.2, 30.1, 79.6, 
122.1, 129.1, 129.9, 150.4, 178.2. 
 
Antimicrobial activity 
The agar well diffusion method was used for examine 
the in vitro antimicrobial activity of synthesized ligands 
L1, L2 & L3. The antimicrobial activity of synthesized 
ligands were screened against both gram positive 
organism such as Staphylococcus aureus and gram 
negative organisms such as E-coli, Klebsiella 
pneumonia, Acinetobacter baumannii, Pseudomonas 
aeruginosa with the quantity of 100µl of concentration 
of 1% solution (10 mg of testing ligand was dissolved in 
1mL of dimethylsulfoxide). 
The microorganisms were inoculated into the 
sterilized nutrient broth and it was maintained at 37°C 
about 24 h. On the day of testing, 100 µL of 
exponentially grown inocula of E.coli-ATCC 25922, 
Staphylococcus aureus - MTCC 1430, Klebsiella 
pneumoniae -MTCC 432, Acinetobacter baumannii- 
ATCC 19606, Pseudomonas aeruginosa -ATCC 27853 
were uniformly spread with the help of L-rod on nutrient 
agar plates. After even spreading of all cultures, 6 mm 
diameter wells were cut on nutrient agar plates and 100 
µL of ligands L1, L2 & L3 were transferred into all the 
wells immediately. 100 µL DMSO is spotted separately 
to compare the effect of solvent on antimicrobial 
activity. The loaded plates were incubated at 37°C about 
24h. The measurement of zone of inhibition was 
determined as radius of the clear zone with the help of 
antibiotic measuring zone scale (Himedia). 
 
 




Scheme 3 — Preparation of L3 





The experiment was performed on mild steel with 
the chemical composition of iron-99.099% and 
carbon-0.084%. The size of rectangular mild steel 
specimens are 5cm × 2cm × 0.05cm (length × width × 
thickness) with a small hole at one end. The 
specimens were polished with 4/0,3/0,2/0 and 1/0 
grade emery papers to remove dusts or other foreign 
matter followed by rinsing thoroughly with double 
distilled water degreased with acetone and dried. 
The initial weight of the specimens was measured. A 
series of 200 mL 0.5N hydrochloric acid solutions were 
prepared using double distilled water. The prior weighed 
specimens are completely immersed into the solution 
through glass hook. The temperature was maintained 
30±2°C about 24 h. The specimens were removed from 
the solution, washed with running water, dried and 
weighed to the accuracy of four decimal places. The 
weight loss of mild steel was calculated by the 
difference between the weight of mild steel before and 
after immersion. The experiment was repeated for the 
different concentrations of L1, L2 & L3 with 0.1, 0.3, 0.5 
and 0.7% respectively. To derive the effect of 
temperature on corrosion inhibition of mild steel, the 
above procedure was carried out at 40±2 and 50±2°C. 
 
Result and Discussion 
 
Mass spectra 
The mass (m/z) is obtained for L1, L2& L3 are 
407.89, 366.69 & 259.1 respectively which are well 
supporting the proposed molecular mass calculated 
from molecular formula for these ligands. Along with 
molecular ion peak, the spectra exhibit some other 






The synthesized new ligands L1 & L2 and standard 
ligand L3 shows a significant vibrational bands 
corresponding to the characteristic functional groups in 
the molecules. The strong evidence for the formation of 
imine(C=N) was found (the sharp and strong stretching 
vibrational band) at 1605 cm
-1 
(for L1), 1612 cm
-1 
(for 
L2) and 1606 cm
-1 
(for L3) and the absence of carbonyl 
(C=O) group stretching vibrational band at 1700cm
-1
 
for L1, L2  & L3. Further, the stretching vibrational band 
at 1727cm
-1
 and 3248 cm
-1
 confirms the presence of 
ester(-COOCH3) and amine(-NH2) group in L1.The 
stretching vibrational band at 1511 cm
-1
 and 839 cm
-1
 
confirms the presence of nitro(-NO2) and C-Cl bond in 
L2
29





confirms the presence of amine(-NH2) and  
C-Cl bond in L3. 
 
Ultraviolet-Visible spectra 
The UV spectra of L1,L2 & L3is showed an intense 
broad peak at 335nm (for L1& L3) and 418nm (for L2) 
due to π -π
*
transition in azomethine group(-C=N)
30
. 
The conjugation of double bond in the imidazole ring 
shifted the wavelength to lower region by the 
bathochromic shift. The probable forbidden n-π
*
 is 
partially overlapped by the allowed π -π
*
 for L1& L3. 
The short band at 305nm is due to n-π
*
transition 







H NMR spectrum of the synthesized ligands 
confirms the structure of the molecule. For L1, the 
thioamide protons have shown the chemical shift values 
of ∂=8.03 and 8.09 as two different singlet due to the 
involvement of one proton in hydrogen bonding with 
imine nitrogen. The secondary amine proton is observed 
as singlet (broad peak) at ∂ value of 11.2. The imine –
CH and methylene (-CH2) attached to imidazole ring is 
shown as singlet at ∂ value of 6.9 and 5.7 respectively
32
. 
The aliphatic protons on the n-butyl side chain attached 
to the imidazole ring are found at ∂ value of 0.81, 1.2, 
1.4 and 2.6. The aromatic protons are observed as 
doublet at ∂ value between 7.1-7.9. For L2, the imine –
CH is found at ∂ of 9.15 as singlet. This is due to the 
deshielding effect of presence of dinitrophenyl group is 
shift to higher ∂ value. The imidazole –NH proton is 
appeared as singlet at ∂ value of 11.3
33
. The aliphatic 
protons on butyl side chain are observed at ∂ value of 
0.95, 1.3, 1.7 and 2.7 respectively. The aromatic protons 
on phenyl ring are observed at ∂ value of 7.2-8.3. For L3, 
the thioamide protons have shown the chemical shift 
values of ∂=7.95 and 8.33 as two different singlet. The 
imine –CH is shown as singlet at ∂ value of 7.83. The 
imidazole –NH proton is appeared as singlet at ∂ value 
of 11.4. The aliphatic protons on butyl side chain are 
observed at ∂ value of 0.98, 1.3, 1.6 and 2.6 respectively. 
The 
13
C NMR spectrum of L1, L2 & L3 are further 
confirmed the formation of imine group in the molecule. 
The imine carbon was shown the peak at ∂ value of 
130.0, 129.8 and 129.9 for L1, L2 & L3 respectively
34
. 
The n-butyl side chain carbon atoms showed the peak at 
∂ value of 14.0, 22.0, 26.0, 29.4 for L1, 14.0, 22.1, 28.1, 
30.2 for L2 and 14.0, 22.1, 28.2, 30.2 for L3. 
 
Antimicrobial activity 
The presence of nitro group (-NO2), secondary 
amine group (-NH) or phenolic hydroxyl group (-OH) 




in the compound which enhances the antimicrobial 
activity
35
. It can be seen from the data that the biological 
study of synthesized new ligand L1 (imidazole –NH of 
L3 is protected with aromatic substituent) has shown 
almost equal activity when compared to standard ligand 
L3 whereas the another new ligand L2( amine part of L3 
is replaced with 2,4-dinitrophenylhydrazine) has shown 
slightly better biological activity against gram negative 
bacteria such as E-coli, Klebsiella pneumonia, 
Acinetobacter baumannii, Pseudomonas aeruginosa and 
gram positive bacteria Staphylococcus aureus when 
compared to standard ligand L3.The ligand bearing 
aromatic ring and hetero atom nitrogen has shown 
promising activity against all the tested fungi
58
. Hence, 
the presence of aromatic ring with hetero atom as key 
atom (nitro phenyl group) enhanced the antimicrobial 
activity than the standard ligand L3
36
.The values of zone 
of inhibition of ligands L1,L2 & L3 is tabulated in Table 1. 
 
Corrosion Study 
The schiff base containing the nitro group showed an 
effective corrosion inhibiton property on mild steel in 
0.5M HCl medium by weight loss method
37
. The present 
corrosion study at different concentration of ligands 
reveals that the corrosion inhibition property was 
increased or weight loss and corrosion rate are decreased 
drastically by doping with 0.1% of ligands with 0.5N 
hydrochloric acid solution. Further, by increasing the 
concentration of ligands from 0.1% to 0.7%, the 
corrosion inhibition efficiency is increased from 87.57 to 
89.74% for L1, 89.71 to 91.76% for L2 and 86.22 to 
88.64% for L3.This might be explained by the donor-
acceptor interaction between the unshared pair of 
electrons of donor atom of the schiff bases and metals in 
the steel. The higher corrosion inhibition property of 
schiff base ligands L1, L2 was due to the increase of 
electron density in L1 by the presence of aromatic π-
electrons and ester group, where as in L2 by the presence 
of nitro group and aromatic π-electrons
38
. The observed 
values are tabulated in Table 2. The presence of 
heteroatoms such as N,O or S in the compound which 
enhances the corrosion inhibition property in an acidic 
environment and the corrosion inhibition efficiency is 
decreased with increase of temperature
39
. The corrosion 
study at different temperature with concentration of 
0.1% of synthesized ligands reveals that the weight loss 
and corrosion rate are increased by increasing the 
temperature from 30±2 to 50±2°C and the corrosion 
inhibition efficiency is decreased from 87.6 to 86.9% for 
L1, 89.7 to 89.3% for L2 and 86.5 to 86.0% for L3 by 
increasing the temperature. The observed values are 
tabulated in Table 3. 
 
From the weight loss measurements, the percentage 
of Inhibition efficiency ( ), Corrosion rate(R) is 
calculated by the following formulae. 
Table 1 ― Zone of inhibition values for ligands L1, L2 & L3 
Human pathogens Quantity (µL) Zones of inhibition (mm) 
Blank Lig-1 Lig-2 Lig-3 
E.coli-ATCC 25922 100 1 15 20 14 
Staphylococcus aureus - MTCC 1430 100 5 13 18 15 
Klebsiellapneumoniae -MTCC 432 100 3 18 22 18 
Acinetobacterbaumannii- ATCC 19606 100 4 16 21 17 
Pseudomonas aeruginosa-ATCC 27853 100 5 14 19 15 
 
Table 2 ― Corrosion Inhibition Efficiency and Corrosion rate of ligands in 0.5N HCl at 30±2°C 
Inhibitor Concentration (%) Weight loss (mg) Inhibition efficiency  (%) Corrosion rate R (mgcm
-2h-1) 
Blank - 82.9345 - 0.3456 
Ligand-1 0.1 10.3123 87.57 0.0430 
0.3 9.2535 88.84 0.0386 
0.5 8.7321 89.47 0.0364 
0.7 8.5122 89.74 0.0355 
Ligand-2 0.1 8.5321 89.71 0.0356 
0.3 7.6132 90.82 0.0317 
0.5 7.0211 91.53 0.0293 
0.7 6.8325 91.76 0.0285 
Ligand-3 0.1 11.4321 86.22 0.0476 
0.3 10.3652 87.50 0.0432 
0.5 9.8652 88.10 0.0411 
0.7 9.4215 88.64 0.0393 




1. Inhibition Efficiency( ) = [(WCorr-WInhi)/WCorr]*100 
  Where, WCorr= Weight loss without inhibitor. 
  WInhi = Weight loss with inhibitor. 
 
2. Corrosion Rate (R) = Weight loss in mg /[Area of 
specimen(cm
2
) * Time (Hr)] 
 
Conclusion 
Schiff base L1 & L2, standard ligand L3 are 
prepared and the structure was confirmed by UV-
Visible, NMR, Mass and IR spectral studies. The new 
L1 and L2 are designed by protecting the imidazole –
NH group of L3with benzyl-4-methylbenzoate (for L1) 
and varying the amine part of L3 with 2,4-
dinitrophenyl hydrazine (for L2).  
The antimicrobial study by well diffusion method is 
performed for L1, L2 & L3 and the results are 
compared with standard ligand L3. 
Corrosion inhibition property on mild steel in 0.5N 
HCl for L1 & L2 and standard ligand L3 has been studied 
by weight loss method at different concentration and 
different temperature. 
Similar biological activity is observed by protecting 
the imidazole –NH with ester substituted phenyl 
derivative (L1) and little improvement in biological 
activity is observed by the amine part is replaced with 
nitro substituted phenyl hydrazine derivatives(L2) when 
compared to standard ligand(L3). All the ligands 
exhibit excellent antimicrobial activity against gram 
negative bacteria E-coli, Klebsiella pneumonia, 
Acinetobacter baumannii, Pseudomonas aeruginosa 
and gram positive bacteria Staphylococcus aureus.  
All the ligands exhibit as good corrosion inhibitor 
on mild steel in 0.5N HCl medium. The corrosion 
inhibition efficiency ( ) is increased gradually and 
corrosion rate (R) is decreased gradually by increasing 
the concentration of ligands from 0.1 to 0.7%. The 
corrosion study at elevated temperature reveals that, the 
corrosion inhibition efficiency ( ) is decreased whereas 
corrosion rate (R) is increased by increasing the 
temperature from 30±2 to 50±2°C. 
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